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Abstract
Analysis of high dimensional data often seeks to identify a subset of
important features and assess their effects on the outcome. Traditional
statistical inference procedures based on standard regression methods
often fail in the presence of high-dimensional features. In recent years,
regularization methods have emerged as promising tools for analyzing
high dimensional data. These methods simultaneously select important
features and provide stable estimation of their effects. Adaptive LASSO
and SCAD for instance, give consistent and asymptotically normal es-
timates with oracle properties. However, in finite samples, it remains
difficult to obtain interval estimators for the regression parameters. In
this paper, we propose perturbation resampling based procedures to
approximate the distribution of a general class of penalized parameter
estimates. Our proposal, justified by asymptotic theory, provides a simple
way to estimate the covariance matrix and confidence regions. Through
finite sample simulations, we verify the ability of this method to give
accurate inference and compare it to other widely used standard deviation
and confidence interval estimates. We also illustrate our proposals with a
data set used to study the association of HIV drug resistance and a large
number of genetic mutations.
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1. INTRODUCTION
Accurate prediction of disease outcomes is fundamental for successful disease pre-
vention and treatment selection. Recent advancement in biological and genomic re-
search has led to the discovery of a vast number of new markers that can potentially
be used to develop molecular disease prevention and intervention strategies. For
example, gene expression analyses have identified molecular subtypes that are associ-
ated with differential prognosis and response to treatment for breast cancer patients
(Perou et al. 2000; Dent et al. 2007). For non-small cell lung cancer patients, a com-
posite score consisting of several biological markers including cyclin E and Ki-67 was
shown to be highly predictive of patient survival (Dosaka-Akita et al. 2001). How-
ever, construction of accurate prediction models with a panel of markers is a difficult
task in general. For example, statistical models for calculating individual cancer risk
have been developed for a few types of cancer in the past two decades (Gail et al.
1989; Thompson et al. 2006; Cassidy et al. 2008; Freedman et al. 2009). However,
much refinement is needed even for the best of these models due to their limited
discriminatory accuracy (Spiegelman et al. 1994; Gail and Costantino 2001).
The increasing availability of new potential markers, while holding great promises
for better prediction of disease outcomes, imposes challenges to model development
due to the high dimensionality in the feature space and the relatively small sample
size. To improve prediction with a large number of promising genomic or biological
markers, an important step is to build a parsimonious model that only includes im-
portant markers. Such a model could reduce the cost associated with unnecessary
marker measurements and improve the prediction precision for future patients. For
such purposes, various regularization procedures such as the LASSO (Tibshirani 1996;
Knight and Fu 2000), the SCAD (Fan and Li 2001, 2002, 2004; Zhang et al. 2006),
the adaptive LASSO (ALASSO; Zou 2006; Wang and Leng 2007), the Elastic Net
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(Zou and Hastie 2005; Zou and Zhang 2009), and one-step local linear approximation
(LLA; Zou and Li 2008) have been developed in recent years. These procedures si-
multaneously identify non-informative variables and produce coefficient estimates for
the selected variables to induce a model for prediction.
These regularization procedures, while effective for variable selection and stable
estimation, yield estimators whose distributions are difficult to approximate. LASSO
type estimators have a non-standard limiting distribution that depends on which
components of the coefficient vector are zero. Since the LASSO type estimator is
not consistent in variable selection, the limiting distribution cannot be estimated di-
rectly. Furthermore, standard bootstrap methods fail when the true coefficient vector
is sparse (Knight and Fu 2000). Recently, Chatterjee and Lahiri (2010) proposed a
truncated LASSO estimator whose distribution can be approximated using a resid-
ual bootstrap procedure. To overcome the difficulties in LASSO estimators, other
regularized procedures such as the SCAD and ALASSO have been proposed. These
estimators possess asymptotic oracle properties including perfect variable selection
and super efficiency. However, our simulation results suggest that in finite samples,
such oracle properties are far from being true and inference procedures based on
asymptotic properties such as those given in Zou (2006) perform poorly especially
when the signal to noise ratio (SNR) is high and the between covariate correlations
are not low. Recently, Po¨tscher and Schneider (2009, 2010) developed theory on the
coverage probabilities of the confidence intervals for ALASSO type estimators under
the orthogonal design. It was shown that estimating the distribution function of the
ALASSO estimator is not feasible when the true parameter is of similar magnitude
to n−
1
2 , where n is the sample size. It is thus generally difficult to develop well per-
formed confidence regions (CRs) and hypothesis testing procedures based on these
regularized estimators. Such difficulties limit their applicability to clinical studies
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where confidence in statistical evidence is crucial for clinical decision making.
In this paper, we propose resampling methods to derive CR and testing proce-
dures for marker effects estimated from regularized procedures such as the ALASSO
and one-step SCAD estimator when the true parameter is fixed. Our preliminary
studies suggest that CRs constructed from such resampling procedures perform much
better than their asymptotic based counterparts. When the fitted model is merely
a working model, many frequently used estimation procedures may fail to produce
stable parameter estimates. Procedures that can provide stable parameter estimates
and valid interval estimates under a possibly misspecified working model are highly
valuable when building a prediction model with high dimensional data. Our proposed
procedures remain valid even if the fitted model fails to hold, provided that the em-
ployed objective function satisfies mild regularity conditions. The rest of the paper
is organized as follows. In Section 2, we introduce the proposed perturbation resam-
pling procedures and describe various methods for constructing confidence regions.
In Section 3, we demonstrate the validity of the proposed procedures in finite samples
via simulation studies. In Section 4, we illustrate our proposed procedure with an
HIV drug resistance study where the goal is to predict phenotypic drug resistance
levels using genotypic viral mutations.
2. RESAMPLING PROCEDURES
Suppose that y = (y1, . . . yn)
T is the n × 1 vector of response variables and xj =
(x1i, . . . , xpi)
T, i = 1 . . . n, are the predictors. Let X = [x1, . . . ,xn]
T be the n×p matrix
of these covariates. Assume that the effect of x on y is determined via an objective
function L(θ;D) = `(y, α + βTx), where θ = (α,βT)T, α is an unknown location
parameter, β is an unknown p × 1 vector of covariate effects, and D = (y,xT)T. To
assess the association between x and y, let L˜(θ) = n−1
∑n
i=1L(θ;Di) be the objective
function used to fit a regression model and θ˜ = (α˜, β˜
T
)T = argminθ L˜(θ). To obtain
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a regularized estimator for θ0, we minimize the regularized objective function
L̂(θ) = L˜(θ) +
p∑
j=1
p′λnj(|β˜j|)|βj| (1)
where p′λnj(|β˜j|) is the derivative of a penalty pλnj(|βj|) evaluated at the initial es-
timate of β0j. We consider the cases where pλnj(|βj|) is the concave SCAD penalty
or the Lq penalty for 0 < q < 1, and utilize a one-step estimator of these penal-
ties with the local linear approximation (LLA) method proposed by Zou and Li
(2008). Additionally, we consider the ALASSO penalty of Zou (2006) that arises
when p′λnj(|β˜j|) = n−
1
2λn|β˜j|−1.
2.1 Regularity Conditions
To ensure the asymptotic oracle properties of the regularized estimators and the valid-
ity of the proposed resampling procedures, we require the following set of conditions:
C1. P{L(θ;D)} has a unique minimum at θ0 and a continuous secondary derivative
with a positive definite A = ∂2P{L(θ;D)}/∂θθT|θ=θ0 > 0, where P is the
probability measure generated by the data X = {Di, i = 1, ..., n}.
C2. The class of functions indexed by θ, {L(θ;D) | θ ∈ Ω}, is Glivenko-Cantelli
(Kosorok 2008), where Ω is the compact parameter space containing θ0.
C3. There exists a “qausi-derivative” function U(θ;D) for L(θ;D) such that for any
positive sequence δn → 0
(a) P{U2(θ0;D)} = B, a positive definite matrix.
(b) P{L(θ;D)−L(θ0;D)−U(θ0;D)(θ − θ0)} = 12(θ − θ0)TA(θ − θ0) + o(‖θ −
θ0‖2), where ‖θ − θ0‖ ≤ δn.
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(c) For ‖θ − θ0‖ ≤ δn = o(1),
sup
θ
P
{
L(θ;D)− L(θ0;D)− U(θ0;D)(θ − θ0)
‖θ − θ0‖
}2
= o(1)
(d) The class of functions
Dn =
{
L(θ;D)− L(θ0;D)− U(θ0;D)(θ − θ0)
‖θ − θ0‖
∣∣∣∣ ‖θ − θ0‖ ≤ δn}
is Donsker (Kosorok 2008, p11).
These conditions are parallel to the conditions required in Proposition A1-A3 in Jin
et al. (2001). These conditions also guarantee that θ˜ is a consistent estimator of θ0
and n
1
2 (θ˜− θ0) converges in distribution to N(0,A−1BA−1). Let A = {j : β0j 6= 0} of
size p 6=0 and Ac = {j : β0j = 0}, where aj denotes the jth component of a vector a.
Following similar arguments to those given in Zou (2006), Zou and Li (2008) and
the unconditional arguments given in the Appendix, θ̂ = argminθ L̂(θ) has ‘good’
properties for certain choices of λn, including the oracle property,
Lemma 1: (Oracle properties) Suppose that λn → 0 and λnn 12 → ∞. Then the
regularized estimates must satisfy the following:
1. Consistency in variable selection: limnpr(Â = A) = 1, where Â = {j : βˆj 6= 0}
2. Asymptotic normality: n
1
2 (θ̂A − θ0 bA)→d N(0,A−111 B11A−111 ), where A11 and B11
are the respective p 6=0 × p 6=0 submatrices of A and B corresponding to A.
This lemma guarantees that the regularized estimate asymptotically chooses the
correct model and has the optimal estimation rate. However, estimating the dis-
tribution of n
1
2 (θ̂ − θ0) in finite samples remains difficult. To estimate the stan-
dard errors of the SCAD estimates θ̂ = argminθ {L˜(θ) +
∑p
j=1 pλnj(|βj|)} when
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L˜(θ) = n−1
∑n
i=1L(θ;Di) is smooth in θ, Fan and Li (2001) proposed a local
quadratic approximation (LQA) method. This gives a sandwich estimator for the
covariance matrix of the estimated nonzero parameters:
ĉov
(
θ̂ bA
)
= {∇2L˜(θ̂ bA) + Σλ(θ̂ bA)}−1ĉov{∇L˜(θ̂ bA)}{∇2L˜(θ̂ bA) + Σλ(θ̂ bA)}−1 (2)
where ∇L˜(θ̂ bA) = ∂L˜(θ̂ bA)/∂θ, ∇2L˜(θ̂ bA) = ∂2L˜(θ̂ bA)/∂θ∂θT , and Σλ(θ̂ bA) is a diagonal
matrix with the (j, j)th element being I(β̂j 6= 0)p′λn1(|β̂j|)/|β̂j|. The LQA approach
can also be used to construct a covariance estimate for the ALASSO estimates where
p′λnj(|β˜j|) = n−
1
2λn|β˜j|−1. Similar to covariance estimates in Tibshirani (1996) and
Fan and Li (2001) for penalized estimates, this procedure estimates the standard
errors for variables with βˆj = 0 as 0. Although this sandwich estimator has been
proven to be consistent (Fan and Peng 2004) under the linear regression model, it
tends to underestimate the standard errors, and normal confidence regions (CRs)
using this estimate often do not provide acceptable coverage in finite sample.
To approximate the covariance of θ̂ more accurately, we propose a perturbation
method to estimate the distribution of n
1
2 (θ̂ − θ0) for a general class of objective
functions and penalties. Let G = {Gi, i = 1, . . . , n} be a set of independent and
identically distributed (i.i.d) positive random variables with mean and variance equal
to one. We first perturb the initial objective function and obtain
L˜∗(θ) = n−1
n∑
i=1
L(θ,Di)Gi, and θ˜
∗
= argmin
θ
L˜∗(θ).
Then with the same set G, we obtain the minimizer of a stochastically perturbed
version of the regularized objective function:
L̂∗(θ) = L˜∗(θ) +
p∑
j=1
p′λ∗nj(|β˜∗j |)|βj| (3)
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where λ∗n satisfies the same order constraints as λn as discussed in the Lemma 1. In
practice, one may select λn and λ
∗
n based on the BIC criterion with the corresponding
objective functions. In the appendix we first show that n
1
2 (θ̂
∗
A − θ0A) converges
in distribution to N(0,A−111 B11A−111 ), the same limiting distribution of n
1
2 (θ̂ − θ0).
Furthermore, P∗(θ̂
∗
Ac = 0) → 1, where P∗ is the probability measure generated by
both X and G. In addition, we show that the distribution of n
1
2 (θ̂
∗
A− θ̂A) conditional
on the data can be used to approximate the unconditional distribution of n
1
2 (θ̂A−θA0)
and that P∗(θ̂
∗
Ac = 0 | X) → 1. In practice, these results allows us to estimate the
distribution of n
1
2 (θ̂ − θ0) by generating a large number, M , say, of random samples
G. We obtain θ̂
∗
m by minimizing the perturbed objective function for each sample
m = 1, . . .M , and then approximate the theoretical distribution of θ̂ by the empirical
distribution {θ̂∗m,m = 1, . . .M}. Specifically, the covariance matrix of θ̂ can be
estimated by the sample covariance matrix constructed from {θ̂∗m,m = 1, . . .M}.
Estimating the distribution of n
1
2 (θ̂−θ0) based on the distribution of n 12 (θ̂
∗−θ̂) | X
leads to the construction of three possible (1−α)100% confidence regions for θ0. For
the first, let σ̂2j = M
−1∑M
m=1(β̂
∗
mj − β̂j)2. We construct a normal CR for β0j, CR*Nj ,
centered at β̂j with standard deviation σ̂
∗
j . This method is in contrast to CR
Asym
obtained with standard deviations σ̂Asymj estimated with the asymptotically consistent
LQA sandwich estimator in Fan and Li (2001) and Zou (2006). In contrast to setting
the standard error to 0 when β̂j = 0, we set CR
*N
j = {0} if the proportion of β̂∗j being
0 is larger than a threshold p̂high, such that p̂high → phigh < 1. This method accounts
for the superefficiency due to the oracle property and results in a shorter interval
with valid coverage. Secondly, we simply take the (α/2)100th and (1 − α/2)100th
quantiles of β̂∗j as the upper and lower bounds of CR
*Q
j . For the third, we estimate
the density of β̂∗j with a kernel density estimator and choose the (1−α)100% highest
density region, CR*HDRj . We estimate the density of β̂
∗
j | X as a mixed density with
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distribution f ∗j (β) = P̂0jI(β = 0) + (1− P̂0j)f ∗j (β),where P̂0j is the proportion of β̂∗j
set to 0, and f ∗j (β) is the unknown distribution of β̂
∗
j given that it is not set to 0.
Thus, our highest density confidence region CR*HDRj is defined as
CR*HDRj =

{0} if P̂0j ≥ p̂high
{β : f ∗j (β) ≥ ĉ1} ∪ {0} if p̂low ≤ P̂0j < p̂high
{β : f ∗j (β) ≥ ĉ2} ∪ {0} if α ≤ P̂0j < max(α, p̂low)
{β : f ∗j (β) ≥ ĉ3} if P̂0j < α
where ĉ1, ĉ2, and ĉ3 are chosen such that for H(c) =
∫
I{f ∗j (β) ≥ c}f ∗j (β)dβ, we have
H(ĉ1) = (1− α− P̂0j)/(1− P̂0j), H(ĉ2) = 1−α+α(P̂0j + p̂low), H(ĉ3) = 1−α, while
p̂low → 0 and p̂high → phigh < 1. The details of this method are relegated to the
Appendix. Note that {0} is included in our confidence region when P̂0 is sufficiently
large, or when f ∗j (β) is sufficiently large around a neighborhood of 0.
In practice, when assessing the effects of multiple features, it is often important
to adjust for multiple comparisons. For interval estimation, we may construct a
(1− α)100% simultaneous confidence region to cover the entire parameter vector θ0.
We may then make statements about the importance of each of the covariates in the
presence of other covariates while maintaining a type I error of α. For the regularized
estimator, we define the simultaneous region as CR*Sim =
∏
j /∈ bA∗{0} ×∏j∈ bA∗(βˆj −
γασˆ
∗
j , βˆj + γασˆ
∗
j ) where Â
∗ = {j : P̂0j < p̂high} and γα is the (1− α)100% quantile of{
max
{
|βˆ∗jm − βˆj|/σ̂∗j
}
j∈ bA∗
}M
m=1
. We compare the performance of these confidence
regions with numerical examples in Sections 3 and 4.
3. SIMULATION STUDIES
To examine the validity of our procedures in finite samples, we performed simu-
lation studies to assess the performance of the corresponding confidence regions. For
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each setting, we simulated 1500 data sets with n observations generated under the
linear model, y = Xβ + , where xij ∼ N(0, 1), the pairwise correlation between xi
and xj was set to cor(xi,xj) = ρ, i ∼ N(0, σ2), and β, ρ, and σ were varied between
settings. In each setting, β was sparse and included medium and high signals. We ob-
tained ALASSO estimators for each simulated data set with λ chosen by the BIC and
then M = 500 perturbed samples using our proposed method with G generated from a
mean 1 exponential distribution. The sample size n was set to 100, 200, 400, or 1000,
while ρ was 0, 0.2, or 0.5, and σ was 1 or 2. To compute the highest density regions
CR*HDR we utilized the hdrcde package in R with the “ndr” bandwidth estimator as
presented in Scott (1992) based on Silverman’s rule of thumb (Silverman 1986). We
chose p̂low = min{(log(n)/n)(1−p/n)/4, 0.49} and p̂high = min{1−n−(1+p/n)/4, 0.95}. We
substituted the σ used in the standard deviation estimate from Zou (2006) analogous
to equation (2) with the known σ from the simulations.
We present the results for simulations with n = 100, 200 and 400 when σ = 1 or
2 and p = 10 or 20. In these cases, the true β0 contains two large effects of β0j = 1,
two moderate effects of β0j = 0.5, and six (for p = 10) or sixteen (for p = 20) noise
parameters where β0j = 0. To examine the effect of regularization we compare our
CRs for the regularized estimators to CROLS, the normal CR based on the empirical
standard error of the perturbed ordinary least squares (OLS) estimates.
[Table 1 and 2 about here.]
In Tables 1 and 2 we see that CR*N usually has better coverage than CRAsym
and CROLS and sacrifices very little in length. The asymmetric CR*HDR has higher
coverage than CRAsym and CROLS for the moderate signal β0j = 0.5 and has the
shortest length when β0j = 0. The other perturbation based confidence region CR
*Q
performs similarly to CROLS when β0j is nonzero. The standard deviation estimate
from Zou (2006), σ̂Asym (also see Table 3), is not large enough to cover β0j sufficiently,
9
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and while the coverage probability of the CROLS is not extremely low, it is notably
outperformed by the other confidence regions when β0j = 0. We omit the results from
the settings where n = 1000 because the results have similar patterns as those with
n = 400. For these large sample cases with n greater than or equal to 400 we saw
convergence to 95% coverage for the normal CRs, highest density regions, and OLS
CRs in all settings when the true parameter was nonzero. For true zero parameters,
the coverage probabilities of our confidence regions converged to 1, while the OLS CR
converged to 0.95. A tradeoff associated with our method is that while the coverage of
our perturbation confidence regions tends to be higher than CROLS and CRAsym, some
power is sacrificed for moderate signals of β0j = 0.5. This loss is minimal, however,
and only appears in difficult cases when sample size is low and ρ and σ are high. We
see that when σ = 1 all CRs except CROLS perform well, though CRAsym still tends
to have slightly lower coverage than perturbation based regions and often does not
reach 95% coverage. Also, when β0j = 0, CR
OLS has coverage lower than 95% for
small samples while our methods produce regions with coverage probability near 1
and very short lengths reflecting the oracle properties. Overall, the most disparity
between our methods and previous methods is seen when the SNR is low.
The coverage probabilities and lengths of our simultaneous confidence regions are
also displayed in Tables 1 and 2. We compared our method to CR*SimOLS, constructed
analogously to CR*Sim except Â∗ = {j|j = 1, . . . , p} and CR*SimOLS is centered at
the OLS estimates and the standard error is the sample standard deviation of the
perturbed OLS estimates. Our regularized CR*Sim has the advantage of shrinking the
dimension of the region by reducing some CRs to the point {0} when P̂0j is large.
We see that our CR*Sim outperforms CR*SimOLS in coverage and has shorter length for
σ = 1 and comparable length for σ = 2. For large sample settings when n = 1000,
CR*SimOLS converges further to 95% coverage with levels around 94% and CR*Sim has
10
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coverage almost always over 95%.
[Table 3 about here.]
In Table 3 we also present the standard error estimates when σ = 2. For notation,
let the empirical standard deviations of the estimators β̂j and β˜j be denoted as σ˜j and
σ˜OLSj , respectively. We see that our estimate of the standard error from the perturbed
samples, σ̂∗j , does well in estimating σ˜j. However, the standard error proposed by Zou
(2006) underestimates the true standard error of the parameter estimates, especially
when σ = 2 and β0j = 0.5 or 0. When the SNR is higher, σ˜
Asym
j estimates σ˜j well
except when β0j = 0 because σˆ
Asym
j = 0 whereas σ˜j and σ̂
∗
j are clearly nonzero.
4. EXAMPLE: HIV DRUG RESISTANCE
We illustrate our methods in a real example using the HIV antiretroviral drug
susceptibility data described in Rhee et al. (2003). This dataset was refined from the
Stanford HIV Drug Resistance Database (available at http://hivdb.stanford.edu/ ),
and is used to study the association of protease mutations with susceptibility to
the protease inhibitor anti-retroviral (ARV) drug amprenavir. The data consist of
mutation information at 99 protease codons in the viral genome, of which 79 contain
mutations, and ARV drug resistance assays for n = 702 HIV infected patients. Drug
resistance was measured in units of IC50, the amount of drug needed to inhibit viral
replication by 50% in units of fold increase compared to drug-sensitive wildtype virus.
Researchers are interested in determining which protease mutations are associated
with ARV resistance so that they may develop a genotype test for resistance that
looks for these mutations in the patient’s infecting HIV strain. Therefore, we aim
to examine the effect of the presence of any of the mutations at 79 codons on IC50,
where higher IC50 measurements indicate higher levels of drug resistance. We chose
to log-transform the non-negative IC50 outcome and represented the presence of each
11
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of the mutations as a binary predictor in our regression model. We removed the
fifteen mutations that occurred less than 0.5% in the data set. Recently, Wu (2009)
analyzed these data with a permutation test for regression coefficients of LASSO. In
this paper, we will analyze the data using ALASSO and gain inference by using our
perturbation methods to construct CRs and standard errors.
For this analysis, we fit an ALASSO linear model with λ chosen to minimize the
BIC. We generated M=500 perturbation variable sets G, consisting of n = 702 i.i.d.
variables from an exponential distribution with mean and variance equal to 1, and for
each G we minimized the perturbed objective function to obtain β̂
∗
m. We constructed
95% CRs using our perturbation method and compared inference gained from CR*N
and CR*HDR to the inference from CRAsym and CROLS. We estimated the σ used in
the standard deviation estimate from Zou (2006) analogous to equation (2) with the
known σ from the simulations.
[Figure 1 about here.]
We present a graphical summary of the analysis results in Figure 1. Previous stud-
ies by Prado et al. (2002) and results collected by Johnson et al. (2005) found that
mutations at codons 10, 32, 46, 47, 50, 54, 73, 82, 84 and 90 emerge in amprenavir
resistant viral genomes. Using a permutation based p-value adjusted for multiple
testing, Wu (2009) determined these mutations (except 73 and 82) as well as addi-
tional codon mutations to be significantly associated with amprenavir susceptibility
at the α = 0.05 level for a total of thirteen significant associations. The ALASSO
estimator estimated the same set of thirteen coefficients as nonzero. The confidence
region from nonregularized estimates CROLS was significant for all sixteen mutations
including these thirteen. However our perturbation based CR*N and CR*HDR for three
of these mutations did include zero. We see in Figure 2 that parameters for codons
48 and 50 have clearly nonsignificant CRs, suggesting that the parameters were esti-
12
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mated as zero in the perturbation samples too often to be deemed significant. The
parameter for codon 32 has marginally nonsignificant confidence regions and P̂0j is
marginally close to 0.05.
[Figure 2 about here.]
Our use of ALASSO provides estimates of the effects of each mutation while ad-
justing for the presence of other mutations. Several studies have shown that mutations
associated with resistance to protease inhibitors can have varying effects when com-
bined with other mutations (Schumi and DeGruttola 2008; Van Marck et al. 2009).
For instance, the mutation at codon 32 has been found to have no effect on resistance
of the protease inhibitor drug darunavir when a mutation at codon 84 is present
(Van Marck et al. 2009). Our method allows us to determine the size of associations
without orthogonalizing predictors and we adjust for multiple testing with the simul-
taneous confidence region CR*Sim. Results could be impacted by studies summarized
in Johnson et al. (2005) that may not have adjusted for other mutations, and the use
of LASSO estimators that do not have oracle properties in Wu (2009). Furthermore,
our methods produce CRs for the coefficients of mutations that were estimated as
zero. These CRs quantify the uncertainty in our estimation and can aid scientists
who wish to conduct future drug therapy studies involving the codons.
5. DISCUSSION
In this paper, we address the problem of constructing a covariance estimate for
parameter estimates obtained with a general objective function and concave penalty
functions including adaptive LASSO and SCAD. The proposed methods for covari-
ance estimates are simple to implement and possess the attractive property that
parameters estimated as zero have nonzero standard errors. We may then construct
confidence regions for each parameter estimate and obtain more meaningful inference.
13
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We have shown through extensive simulation studies using the ALASSO penalty
that our perturbation method results in confidence regions with accurate coverage
probability. The perturbation based normal CR does not sacrifice much in length
and has reasonable coverage for small sample sizes. We set the CR to {0} when the
proportion of perturbed estimates set to 0 is higher than a threshold, and therefore
shorten the length by utilizing the oracle property. The perturbation based highest
density region has even shorter length and good coverage probability, especially for
the moderate signal β0j = 0.5 in comparison to all other confidence regions. The
asymptotic based normal interval that uses the standard error estimate presented in
Zou (2006) fails to reach nominal coverage levels due to the underestimation of the
standard error, most notably when the standard error is estimated as 0 when β̂ =
0. However, our estimate of the standard error of the parameter estimates based on
our perturbation samples is close to the empirical standard error of the ALASSO
estimates, even for parameters estimated as 0. Additionally, we propose a simultane-
ous CR that adjusts for multiple comparisons. We again utilize the oracle property
and reduce the dimension of our region by setting intervals to {0} when the propor-
tion of zero perturbed parameter estimates is high. Therefore, the average length
of our region will often be shorter than the simultaneous OLS region. For instance,
when all covariates are independent, the OLS length is asymptotically proportional
to γOLS = max
{∣∣∣(β˜j − β0j)/σ∣∣∣}p
j=1
whereas the perturbation region length is asymp-
totically proportional to (p 6=0/p)γ where γ = max
{∣∣∣(β̂j − β0j)/σ∣∣∣}
β0j 6=0
. Note that
γ ≤ γOLS and so the length of the perturbation region will be shorter than the OLS
length when the true model is sparse. Similarly, when the covariates are not inde-
pendent,
{
(β˜j − β0j)/σ
}p
j=1
∼ N(0,Corr(β̂)) and the perturbation region generally
has shorter average length than the OLS region. Simple simulations show that when
p 6=0 parameters are estimated as nonzero, we expect the perturbation region length
14
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to be approximately 0.36 times the OLS region length when p = 10 and p 6=0 = 4 and
approximately 0.16 times the OLS region length when p = 20 and p 6=0 = 4 for both
the independent case and the compound symmetry case when ρ = 0.5 and σ = 1.
Additionally, it is well known that regularized estimators, while possessing asymp-
totic oracle properties, are prone to bias in finite samples. Bias correction for
the ALASSO estimator can be achieved based on our perturbation samples. We
present the technical details of the estimation of the bias in the appendix. We
find that this bias correction works well in practice, especially when the signal is
small or moderate, as when β0j = 0.5. For example, in our simulations when
p = 20, n = 100, ρ = 0.5, σ = 1, and β0j = 0.5, the bias of β̂j is -0.071 while the
bias of β̂BC0j is -0.042. Similar gains are seen for most settings. The bias corrected esti-
mator has empirical standard error similar to that of the original ALASSO estimator
but with smaller bias. We could construct analogous bias-corrected estimators based
on other penalties and objective functions. The model size with the ALASSO and
bias-corrected ALASSO estimator in our simulations is very close to 4 when σ = 1,
except for the difficult cases when n = 100 and p = 20 for which the average model
size is closer to 4.5. For the settings where the SNR is low with σ = 2, the oracle
property is weak in finite samples and so the model size is between 5 and 6 when
p = 10 and between 7 and 10 when p = 20. We note that when p is large relative to
n, initial parameter estimates obtained with ridge regression can produce more stable
results. Also, our methods are robust to misspecification of the model and are valid
even when the true model is not sparse.
APPENDIX
A.1 Justification for the Resampling Method
To show that the distribution of n
1
2 (θ̂ − θ0) can be estimated by that of n 12 (θ̂
∗ − θ̂) |
X under conditions C1-C3, we first consider the distribution of n
1
2 (θ̂
∗ − θ0) under
15
http://biostats.bepress.com/harvardbiostat/paper119
the product probability measure P∗ generated by the data, X, and the perturbation
variables G = {Gi, i = 1, . . . , n}. Throughout, we assume that the parameter space
for θ, denoted by Ω, is a compact set and θ0 is an interior point of Ω. We let Pn denote
the empirical measure generated by X and Gn = n−
1
2 (Pn − P). We use notation →p
to denote convergence in probability.
We first show that θ̂
∗ →p θ0. First note that
∑p
j=1 p
′
λ∗nj(|β˜∗j |)|βj| → 0 in probabil-
ity. When the penalty is Lq, p
′
λ∗nj(|β˜∗j |) = λn|βj|q, p′(|β˜∗j |)→p p′(|β0j|) by the contin-
uous mapping theorem and λn → 0. For the SCAD penalty, p′λ∗nj(|β˜∗j |) = λnI(|β˜∗j | ≤
λn) + (aλn − |β˜∗j |)+I(|β˜∗j | > λn)/(a − 1). We consider two cases: (i) β0j 6= 0, and
(ii) β0j = 0. For case (i), λn → 0 and |β˜∗j | →p |β0j|. Thus, I(|β˜∗j | ≤ λn) →p 0 and
(aλn − |β˜∗j |)+ →p 0. For case (ii), λn → 0 and (aλn − |β˜∗j |)+ →p 0. Finally, for
the ALASSO penalty, p′λ∗nj(|β˜∗j |) = λn|n
1
2 β˜∗j |−1, |n
1
2 β˜∗j | = OP(1), and λn → 0. Now,
since the class of functions indexed by θ, {L(θ;D)G : θ ∈ Ω}, is Glivenko-Cantelli,
|L̂∗(θ) − P{L(θ;D)}| ≤ |(Pn − P){L(θ;D)G}| +
∑p
j=1 p
′
λ∗nj(|β˜∗j |)|βj| uniformly con-
verges to zero. This implies the convergence of θ̂
∗ →p θ0.
We next show that ‖θ̂∗ − θ0‖ = OP∗(n− 12 ). It is sufficient to show that for any
 > 0, there exits C > 0 such that
P∗
(
inf
‖θ−θ0‖≥Cn−
1
2
L̂∗(θ) > L̂∗(θ0)
)
> 1−  (A.1)
Since Dn is Donsker, the class of functions
{
L(θ;D)G− L(θ0;D)G− U(θ0;D)G(θ − θ0)
‖θ − θ0‖ : ‖θ − θ0‖ ≤ δn
}
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is P∗-Donsker as well and
sup
‖θ−θ0‖≤δn
∣∣∣∣ Gn{L(θ;D)G− L(θ0;D)G− U(θ0;D)G(θ − θ0)‖θ − θ0‖
} ∣∣∣∣= oP∗(1).
This implies uniformly for θ ∈ {θ : ‖θ − θ0‖ ≤ δn}
L˜∗(θ) = L˜∗(θ0) +Pn{U(θ0;D)G}(θ − θ0) + 1
2
(θ − θ0)TA(θ − θ0) + oP∗(‖δ2n + n−
1
2 δn‖).
(A.2)
Letting θ = θ0 + n
− 1
2u, it follows from (A.2) that we may approximate n{L̂∗(θ0 +
n−
1
2u)−L̂∗(θ0)} with Gn{U(θ0;D)G}u+ 12uTAu+n
∑p
j=1 p
′
λ∗nj(|β˜∗j |)
(∣∣∣β0j + n− 12uj∣∣∣−
|β0j|) + oP∗(‖u‖2 + ‖u‖). Therefore, 12uTAu is the dominating term for the difference
and one may select sufficiently big C such that (A.1) holds.
Now we show the “consistency” of variable selection, i.e., P∗(θ̂
∗
Ac = 0) → 1 as
n → ∞. It suffices to to show that for any constant C and given θ˜A such that
‖θ˜A − θ0A‖ = OP∗(n− 12 )
P∗
[
argmin‖θAc‖≤Cn−
1
2
L̂∗
{(
θ˜
T
A, θ
T
Ac
)T}
= 0
]
→ 1. (A.3)
Let u˜A and uAc denote n
1
2 (θ˜A − θ0A) and n 12 θAc , respectively. It follows from (A.2)
n
[
L̂∗
{(
θT0A + n
− 1
2 u˜TA, n
− 1
2uTAc
)T}
− L̂∗
{(
θT0A + n
− 1
2 u˜TA, 0
T
)T}]
= [Gn{U(θ0;D)TAcG}+ u˜TAA12]uAc +
1
2
uTAcA22uAc + n
∑
j∈Ac
p′λ∗nj(|β˜∗j |)|n−
1
2uj|
+ oP∗(‖uAc‖2 + ‖uAc‖) =
∑
j∈Ac
n
1
2p′λ∗nj(|β˜∗j |) |uj|+Rn(uAc).
where sup‖uAc‖≤C Rn(uAc)/ (‖uAc‖2 + ‖uAc‖) = oP∗(1). Zou and Li (2008) consider
the limiting behavior of n
1
2p′λ∗nj(|β˜∗j |) for SCAD and Lq penalties in their proof of the
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oracle properties of the one-step LLA estimator. They show that for both cases, when
j ∈ Ac, n 12p′λ∗nj(|β˜∗j |) →p ∞. Additionally, for the ALASSO penalty, n
1
2p′λ∗nj(|β˜∗j |) =
n−
1
2λn|n 12 β˜∗j |−1, when j ∈ Ac, we have n−
1
2λn →∞ and |n 12 β˜∗j | = OP∗(1). Hence, for
all three types of penalties, n
1
2p′λ∗nj(|β˜∗j |)→p ∞. Thus, for any  > 0, there exist C1 >
C0 > 0 and N0 such that P∗
{∑
j∈Ac n
1
2p′λ∗nj(|β˜∗j |) |uj| ≥ C1
∑
j∈Ac |uj|
}
≥ 1 −  and
P∗
{
C0
∑
j∈Ac |uj| ≥ |Rn(uAc)|
}
≥ 1− for ‖uAc‖ ≤ C and n ≥ N0. This implies that
with probability greater than 1 − 2, n
[
L̂∗
{(
θ˜
T
A, n
− 1
2uTAc
)T}
− L̂∗
{(
θ˜
T
A, 0
T
)T}]
≥
(C1 − C0)
∑
j∈Ac |uj| ≥ 0, which implies (A.3).
Lastly, we will justify the oracle property of θ̂
∗
A. Since P∗(θ̂
∗
Ac = 0) → 1, θ̂
∗
A can
be considered as the minimizer of L̂∗A(θA) = L̂
∗{(θTA, 0T)T}. Following the approach
of Zou (2006), we consider the reparametrization
L̂∗A(θ0A+n
− 1
2uA) = PnL
{(
θT0A + n
− 1
2uTA, 0
T
)T
,Di
}
Gi+
∑
j∈A
p′λ∗nj(|β˜∗j |)
∣∣∣β0j + n− 12uj∣∣∣ .
(A.4)
Let uˆ
(n)
A = arg minuA L̂
∗
A(θ0A + n
− 1
2uA). Note uˆ
(n)
A = n
1
2 (θ̂
∗
A − θ0A) is also the
minimizer of V ∗n (uA) ≡ L̂∗A(θ0A + n−
1
2uA) − L̂∗(θ0), as L̂∗(θ0) is a constant. Again,
it follows from (A.2)
V ∗n (uA) = n
1
2uTAPn{UA(θ0,D)G}+
1
2
uTAA11uA
+n
∑
j∈A
p′λ∗nj(|β˜∗j |)
(∣∣∣β0j + n− 12uj∣∣∣− |β0j|)+ oP∗(‖uA‖2 + ‖uA‖)
To examine the limiting behavior of the third term of V ∗n (u), we have β0j 6= 0,
n
1
2 (|βj0 + n− 12uj| − |βj0|) →p uj sgn(β0j), since j ∈ A. Also, as Zou and Li
(2008) proved in their appendix, n
1
2p′λ∗nj(|β˜∗j |) →p 0 when j ∈ A for the SCAD
and Lq penalties. For the ALASSO penalty, n
1
2p′λ∗nj(|β˜∗j |) = λn|β˜j|−1, λn → 0,
and |β˜j|−1 →p |β0j|−1 for β0j 6= 0. Therefore, by Slutsky’s theorem, we have
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np′λ∗nj(|β˜∗j |)
(∣∣∣β0j + n− 12uj∣∣∣− |β0j|) = oP∗(1) and
V ∗n (uA) = u
T
AGn{UA(θ0,D)G}+
1
2
uTAA11uA + oP∗(1 + ‖uA‖2 + ‖uA‖).
Thus, uˆ
(n)
A = −A−111 Gn{UA(θ0,D)G} + oP∗(1). Since Gn{UA(θ0,D)G} converges to
N(0,B11) in distribution, n
1
2 (θ̂
∗
A − θ0A)→d N(0,A−111 B11A−111 ) and P∗(θ̂
∗
AC = 0)→ 1.
Then the perturbed regularized estimator θ̂
∗
is asymptotically normal in the true
nonzero parameter set.
Similar arguments as given above can be used to justify that the distribution of
n
1
2 (θ̂
∗ − θ̂) | X approximates that of n 12 (θ̂ − θ0). Specifically, we can similarly obtain
n
1
2 (θ̂A − θ0A) = −A−111 Gn{UA(θ0,D)} + oP(1) and P∗(θ̂AC = 0) → 1. Therefore,
n
1
2 (θ̂
∗
A− θ̂A) = −A−111 Gn{UA(θ0,D)(G− 1)}+ oP∗(1). Since −A−111 Gn{UA(θ0,D)(G−
1)} | X →d N(0,A−111 B̂11A−111 ) and B̂11 →P B11, n
1
2 (θ̂
∗
A − θ̂A) | X and n
1
2 (θ̂A − θ0A)
converge in distribution to the same limit. Furthermore, P∗(θ̂
∗
AC = 0|X)→ 1.
A.2 Justification of highest density region and bias estimate
For j ∈ AC , P∗(β̂∗j = 0) → 1 and thus for any α > 0, P∗(P̂0j > α) → 1,
and P(P̂0j < p̂high) + P(P̂0j < p̂low) → 0. Hence, P∗(0 ∈ CR*HDRj ) → 1. For
j ∈ A, n 12 (β̂∗j − β̂j) | X →d N(0, σ2j ) and P̂0j →p 0, where σ2j is the asymptotic
variance of n
1
2 (β̂j − β0j). It follows that supx |n−
1
2f ∗j (β̂0j + n
− 1
2x) − φσj(x)| →p 0
where φσ(x) = φ(x/σ)/σ and φ(·) is the density function of the standard normal.
Therefore, supβ |n−
1
2f ∗j (β) − φσj{n
1
2 (β − β̂0j)}| →p 0 and n− 12 ĉ3 →p c30, where c30
is the solution to
∫
I{φσj(x) > c30}φσj(x)dx = 1 − α. It follows that with re-
spect to probability measure P∗, pr(β0j ∈ CR*HDRj ) = pr
{
f ∗j (β0j) ≥ ĉ3
}
+ oP∗(1) =
pr
{
n−
1
2f ∗j (β0j) ≥ n−
1
2 ĉ3
}
+ oP∗(1) = pr
[
φσj{n
1
2 (β0j − β̂0j)} ≥ c30
]
+ oP∗(1)→ 1−α.
Here we define our bias corrected estimator for β0j, β̂
BC
j = β̂j + I(β̂j 6= 0)b̂iasj,
where b̂iasj =
(
1
M
∑M
m=1 β̂
∗
j,m
)
(−1)I[
PM
m=1{I(bβ∗j,m>0)−I(bβ∗j,m<0)}<0] (Â−1λ )
jj
/{nmax(|ξ̂7.5|,
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|ξ̂97.5|)}, Âλ = n−1
(
XTbAX bA + n− 12λndiag
{
1/β˜2j
}p
j=1
)
and ξ̂r is the r percentile of
{β˜∗j,m,m = 1, . . .M}. We estimate A for ALASSO with Âλ following the methods of
Cai et al. (2009) where a stabilized estimate of the covariance of coefficients from an
accelerated failure time model is used.
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Table 1: Coverage probabilities (lengths) of confidence regions when σ = 1.
p β0
n = 100 n = 200 n = 400
ρ = 0 ρ = 0.2 ρ = 0.5 ρ = 0 ρ = 0.2 ρ = 0.5 ρ = 0 ρ = 0.2 ρ = 0.5
10 1 CR*N 92.7 (40) 93.5 (42) 93.7 (55) 95.3 (28) 94.9 (30) 95.6 (38) 94.9 (20) 94.6 (21) 95.3 (26)
CR*HDR 92.2 (39) 92.3 (42) 92.8 (54) 94.8 (28) 94.5 (29) 94.3 (37) 94.4 (20) 94.2 (21) 94.7 (26)
CR*Q 91.5 (39) 92.0 (42) 92.8 (54) 94.2 (28) 94.7 (29) 94.3 (37) 93.8 (19) 94.0 (21) 94.7 (26)
CRZou 93.3 (40) 94.5 (42) 92.3 (51) 95.3 (28) 95.1 (29) 94.8 (36) 94.9 (20) 94.6 (21) 94.6 (25)
CROLS 91.8 (38) 91.5 (40) 91.7 (51) 94.3 (27) 94.5 (29) 94.4 (36) 94.7 (19) 93.9 (21) 93.7 (26)
0.5 CR*N 95.3 (45) 95.1 (49) 92.2 (64) 93.3 (30) 96.1 (32) 96.5 (42) 94.3 (20) 95.7 (22) 95.3 (28)
CR*HDR 92.8 (41) 93.9 (43) 92.7 (53) 91.2 (29) 93.8 (31) 93.5 (39) 93.5 (20) 95.1 (21) 94.1 (27)
CR*Q 90.9 (44) 90.5 (47) 90.9 (60) 90.7 (29) 93.6 (31) 92.3 (41) 93.3 (20) 94.9 (21) 94.1 (27)
CRZou 90.9 (40) 89.7 (42) 88.3 (49) 90.6 (28) 93.7 (29) 90.5 (36) 93.4 (20) 94.4 (21) 92.7 (25)
CROLS 92.7 (38) 91.9 (40) 90.9 (51) 92.5 (27) 94.3 (29) 92.1 (36) 93.4 (19) 94.2 (21) 94.3 (26)
0 CR*N 99.7 (8) 99.9 (7) 99.9 (9) 99.8 (4) 99.9 (5) 100 (5) 99.9 (2) 100 (2) 100 (3)
CR*HDR 99.9 (4) 100 (4) 99.9 (5) 100 (2) 99.9 (2) 100 (2) 100 (1) 100 (1) 100 (1)
CR*Q 100 (19) 100 (20) 100 (25) 100 (12) 99.9 (12) 100 (16) 100 (7) 100 (7) 100 (9)
CROLS 92.4 (38) 90.9 (41) 92.8 (51) 94.3 (27) 93.3 (29) 93.3 (36) 94.5 (19) 94.7 (21) 93.9 (26)
CR*Sim 94.9 (29) 93.7 (30) 90.4 (39) 95.3 (19) 96.0 (20) 97.3 (26) 94.3 (13) 94.9 (13) 96.6 (17)
CR*SimOLS 87.7 (54) 85.8 (58) 85.7 (73) 90.7 (39) 91.9 (42) 90.5 (52) 92.5 (28) 93.2 (30) 93.3 (37)
20 1 CR*N 92.7 (40) 93.5 (43) 93.6 (57) 93.1 (28) 94.2 (30) 94.9 (38) 93.3 (20) 94.7 (21) 94.8 (27)
CR*HDR 91.2 (39) 92.6 (42) 92.5 (55) 91.8 (27) 93.5 (30) 93.9 (38) 92.5 (19) 94.6 (21) 94.0 (26)
CR*Q 90.7 (39) 92.1 (42) 92.1 (55) 91.7 (27) 92.9 (29) 94.0 (38) 92.3 (19) 94.5 (21) 94.0 (26)
CRZou 92.7 (40) 94.1 (42) 90.7 (52) 93.0 (28) 93.9 (29) 93.6 (36) 93.1 (20) 94.1 (21) 93.8 (25)
CROLS 90.3 (38) 90.3 (42) 90.3 (52) 91.6 (27) 92.1 (29) 90.9 (37) 93.0 (19) 93.3 (21) 92.7 (26)
0.5 CR*N 93.3 (46) 93.4 (50) 90.5 (66) 93.9 (30) 94.7 (33) 96.2 (44) 93.5 (21) 93.2 (22) 95.3 (29)
CR*HDR 89.5 (42) 92.1 (45) 91.8 (55) 92.1 (30) 90.4 (32) 93.3 (41) 91.8 (20) 91.1 (22) 92.6 (28)
CR*Q 86.1 (44) 86.9 (48) 88.5 (61) 91.1 (30) 89.7 (32) 91.8 (43) 91.3 (20) 90.9 (22) 92.6 (28)
CRZou 85.3 (40) 85.9 (42) 84.9 (48) 91.3 (28) 90.2 (29) 88.1 (36) 91.9 (20) 91.4 (21) 91.8 (25)
CROLS 90.9 (38) 89.5 (41) 90.6 (52) 92.5 (27) 92.3 (29) 92.0 (37) 93.7 (19) 93.2 (21) 93.5 (26)
0 CR*N 100 (6) 100 (5) 99.9 (7) 99.7 (3) 100 (3) 99.9 (4) 100 (2) 99.9 (2) 99.8 (2)
CR*HDR 100 (3) 100 (3) 100 (4) 99.9 (1) 100 (1) 100 (2) 100 (1) 100 (1) 100 (1)
CR*Q 100 (13) 100 (14) 100 (18) 99.9 (8) 100 (9) 100 (11) 100 (5) 100 (5) 100 (7)
CROLS 90.4 (38) 90.9 (41) 89.9 (52) 93.6 (27) 93.6 (29) 91.7 (37) 93.7 (19) 94.0 (21) 92.4 (26)
CR*Sim 93.0 (19) 93.6 (19) 88.3 (25) 95.3 (11) 96.6 (12) 97.2 (16) 95.3 (7) 95.7 (8) 96.5 (10)
CR*SimOLS 78.3 (58) 78.5 (64) 77.6 (80) 86.9 (41) 85.2 (45) 86.6 (57) 90.9 (29) 90.1 (32) 91.3 (41)
NOTE: We multiply values by 100. The lengths of the simultaneous confidence regions are averaged over the number of parameters.http://biostats.bepress.com/harvardbiostat/paper119
Table 2: Coverage probabilities (lengths) of confidence regions when σ = 2.
p β0
n = 100 n = 200 n = 400
ρ = 0 ρ = 0.2 ρ = 0.5 ρ = 0 ρ = 0.2 ρ = 0.5 ρ = 0 ρ = 0.2 ρ = 0.5
10 1 CR*N 93.5 (78) 92.7 (84) 91.4 (109) 93.2 (55) 94.0 (59) 94.2 (75) 93.5 (39) 94.4 (42) 94.9 (53)
CR*HDR 92.7 (76) 91.3 (82) 93.9 (103) 93.2 (54) 93.2 (58) 93.0 (74) 92.9 (39) 94.0 (42) 94.5 (52)
CR*Q 92.8 (77) 91.0 (83) 90.9 (106) 93.2 (54) 93.1 (58) 93.2 (74) 93.1 (39) 93.7 (41) 94.4 (52)
CRZou 82.3 (58) 80.2 (61) 78.7 (74) 81.6 (40) 82.5 (42) 79.3 (52) 82.7 (28) 82.1 (30) 82.7 (36)
CROLS 92.0 (75) 91.7 (81) 91.2 (102) 93.2 (54) 93.8 (58) 93.1 (73) 92.8 (39) 94.0 (42) 94.5 (52)
0.5 CR*N 88.2 (81) 87.7 (86) 85.9 (107) 93.2 (58) 93.0 (63) 90.3 (79) 94.5 (40) 94.1 (44) 95.4 (56)
CR*HDR 92.3 (74) 91.4 (78) 91.7 (97) 95.3 (54) 94.6 (58) 92.4 (70) 93.7 (39) 92.7 (42) 95.9 (52)
CR*Q 91.1 (76) 90.7 (80) 91.8 (98) 92.5 (57) 92.3 (61) 92.8 (75) 93.8 (40) 93.0 (43) 94.4 (55)
CRZou 79.1 (53) 76.3 (55) 70.7 (60) 79.3 (39) 78.7 (41) 76.1 (49) 81.5 (28) 79.8 (29) 79.9 (36)
CROLS 91.3 (75) 91.5 (81) 91.6 (102) 93.0 (54) 92.6 (58) 93.2 (73) 94.1 (39) 93.1 (42) 94.3 (52)
0 CR*N 96.3 (69) 97.0 (72) 96.7 (92) 97.9 (51) 98.0 (54) 97.8 (66) 98.3 (36) 98.2 (39) 98.7 (49)
CR*HDR 98.1 (60) 98.3 (61) 98.5 (79) 99.3 (38) 98.9 (40) 99.1 (50) 99.1 (25) 99.1 (26) 99.6 (33)
CR*Q 99.0 (66) 98.7 (70) 99.1 (88) 99.7 (46) 99.7 (50) 99.6 (62) 99.9 (33) 99.8 (35) 99.7 (44)
CROLS 91.5 (75) 90.9 (81) 91.2 (102) 93.7 (54) 92.7 (58) 93.4 (73) 94.0 (39) 94.3 (41) 93.9 (52)
CR*Sim 91.7 (110) 91.7 (116) 91.2 (148) 96.0 (82) 95.9 (87) 95.3 (109) 98.5 (59) 98.9 (64) 98.2 (80)
CR*SimOLS 85.6 (108) 86.2 (116) 87.1 (146) 90.7 (77) 91.3 (83) 92.2 (104) 91.5 (55) 93.1 (59) 93.1 (74)
20 1 CR*N 91.0 (79) 91.7 (87) 91.7 (111) 92.6 (54) 92.7 (60) 93.9 (77) 93.3 (39) 94.3 (42) 93.3 (54)
CR*HDR 90.3 (77) 90.0 (84) 93.5 (106) 92.4 (54) 92.4 (59) 92.6 (75) 93.4 (38) 93.6 (42) 92.5 (53)
CR*Q 90.3 (77) 89.5 (85) 91.2 (108) 91.9 (54) 92.1 (59) 92.0 (75) 93.2 (38) 93.4 (42) 92.5 (53)
CRZou 79.5 (59) 80.0 (63) 79.5 (78) 82.0 (40) 81.9 (43) 81.2 (53) 81.5 (28) 81.5 (30) 80.9 (37)
CROLS 89.6 (76) 90.3 (83) 90.5 (104) 92.3 (53) 92.2 (59) 92.0 (74) 93.5 (38) 93.4 (42) 92.5 (53)
0.5 CR*N 86.0 (80) 84.7 (87) 81.3 (106) 92.5 (58) 91.1 (64) 88.5 (80) 93.7 (40) 94.1 (44) 93.3 (57)
CR*HDR 90.7 (75) 89.5 (81) 88.0 (100) 94.4 (55) 94.5 (59) 92.4 (73) 92.3 (39) 92.2 (43) 94.8 (54)
CR*Q 89.8 (75) 89.3 (80) 87.1 (96) 91.9 (57) 91.5 (61) 92.7 (75) 92.5 (40) 92.4 (44) 92.9 (56)
CRZou 75.5 (53) 73.5 (55) 68.1 (62) 79.0 (40) 77.7 (42) 74.5 (49) 78.7 (28) 79.7 (30) 75.9 (37)
CROLS 89.9 (76) 89.0 (83) 87.9 (104) 92.5 (54) 91.9 (59) 92.8 (74) 92.9 (38) 92.7 (42) 93.4 (53)
0 CR*N 96.7 (65) 96.4 (71) 97.3 (90) 98.1 (47) 98.2 (52) 98.3 (66) 98.3 (34) 98.8 (37) 98.3 (47)
CR*HDR 97.6 (61) 97.9 (66) 98.1 (83) 98.9 (41) 98.7 (45) 99.1 (58) 98.9 (27) 99.3 (30) 98.8 (38)
CR*Q 98.8 (61) 98.6 (66) 99.1 (84) 99.5 (44) 99.2 (47) 99.7 (60) 99.4 (31) 99.6 (33) 99.5 (42)
CROLS 88.7 (76) 89.4 (83) 89.5 (104) 91.9 (54) 92.9 (59) 93.1 (74) 93.4 (38) 95.3 (42) 92.7 (53)
CR*Sim 93.9 (122) 93.4 (133) 91.9 (167) 97.9 (90) 97.7 (98) 97.1 (125) 99.7 (66) 99.6 (72) 99.3 (91)
CR*SimOLS 79.3 (117) 80.0 (128) 76.9 (161) 86.9 (82) 84.9 (90) 89.1 (114) 89.7 (59) 90.8 (64) 89.9 (81)
NOTE: We multiply values by 100. The lengths of the simultaneous confidence regions are averaged over the number of parameters.
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Table 3: Empirical s.d. of the parameter estimates (σ˜) and average s.e. estimates (σˆ).
p β0
n = 100 n = 200 n = 400
ρ = 0 ρ = 0.2 ρ = 0.5 ρ = 0 ρ = 0.2 ρ = 0.5 ρ = 0 ρ = 0.2 ρ = 0.5
10 1 σ˜ 21.2 24.0 30.1 14.8 15.6 19.9 10.4 11.0 13.5
σ˜OLS 20.9 23.8 28.8 14.7 15.4 19.6 10.4 11.0 13.5
σ̂∗ 19.9 21.5 27.7 14.0 15.1 19.2 10.0 10.7 13.5
σ̂OLS 19.2 20.6 25.9 13.8 14.8 18.5 9.9 10.6 13.3
σ̂Zou 14.8 15.5 19.0 10.2 10.8 13.2 7.1 7.5 9.2
0.5 σ˜ 23.3 25.1 31.1 15.5 16.9 21.9 10.5 11.5 14.3
σ˜OLS 21.6 23.2 29.2 14.6 15.9 19.9 10.2 11.1 13.7
σ̂∗ 20.6 22.1 27.8 14.8 16.0 20.2 10.3 11.1 14.3
σ̂OLS 19.1 20.5 26.1 13.8 14.8 18.6 9.8 10.6 13.3
σ̂Zou 13.6 14.0 15.4 10.1 10.6 12.4 7.1 7.5 9.2
0 σ˜ 17.3 18.0 22.8 10.7 11.3 14.3 7.2 7.5 9.4
σ˜OLS 21.9 23.1 29.5 14.3 15.7 19.5 10.3 10.8 13.7
σ̂∗ 18.6 19.8 25.2 13.2 14.3 17.7 9.4 10.0 12.7
σ̂OLS 19.2 20.6 26.0 13.8 14.8 18.5 9.9 10.6 13.3
σ̂Zou 5.7 5.5 6.8 3.1 3.2 3.9 1.9 1.8 2.4
20 1 σ˜ 22.9 25.0 31.9 14.9 16.1 20.4 10.4 11.3 14.2
σ˜OLS 22.9 24.8 31.3 14.9 16.2 20.6 10.5 11.5 14.5
σ̂∗ 20.1 22.1 28.4 13.9 15.3 19.6 9.9 10.8 13.7
σ̂OLS 19.3 21.2 26.5 13.6 14.9 18.8 9.8 10.7 13.4
σ̂Zou 15.0 16.1 19.9 10.3 11.0 13.6 7.1 7.6 9.5
0.5 σ˜ 24.0 26.5 33.1 16.0 17.7 22.9 11.0 11.8 15.4
σ˜OLS 22.5 24.9 32.8 14.9 16.5 20.5 10.5 11.5 14.3
σ̂∗ 20.6 22.4 27.4 14.8 16.2 20.5 10.3 11.3 14.6
σ̂OLS 19.3 21.1 26.6 13.7 14.9 18.8 9.8 10.7 13.5
σ̂Zou 13.5 14.1 15.9 10.2 10.8 12.6 7.2 7.6 9.4
0 σ˜ 17.1 17.8 22.5 10.0 10.8 13.2 6.4 6.5 8.7
σ˜OLS 23.6 24.9 32.1 14.8 16.1 20.5 10.3 10.8 14.3
σ̂∗ 17.4 18.9 24.0 12.2 13.4 17.2 8.8 9.6 12.2
σ̂OLS 19.3 21.1 26.6 13.7 14.9 18.9 9.8 10.7 13.5
σ̂Zou 5.9 5.8 7.8 3.1 3.3 4.2 1.7 1.7 2.2
NOTE: We present results for settings when σ, the standard deviation of , is 2. All
values are multiplied by 100. Note that σˆZouj = 0 when βˆj = 0, but βˆj and βˆ
∗
j are not
always 0 in the simulations, and therefore the average σˆZouj is nonzero.
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Figure 1: Perturbation methods results denoting significant associations between genetic mutations and drug susceptibility.
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Figure 2: 95% perturbation CRs (CR*N and CR*HDR) for the association between genetic mutations and antiretroviral drug
susceptibility. Estimated coefficients β̂j are represented with a circle on each CR line and a star at zero signifies that the
CR includes the point mass at zero. The shaded region denotes the simultaneous confidence region CR*Sim. Note that even
coefficients estimated as zero may have CRs around their estimates and that CR*HDR may be asymmetrical and noncontiguous.
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